Join AiCuris

Science.Health.Life

AiCuris - founded in 2006 - is a specialist for infectious diseases. Its focus comprises discovery, research and development of novel antiviral and antibacterial agents in the indications Human Cytomegalovirus, Herpes simplex, Hepatitis B, and (multi)resistant bacterial infections treated in the hospital. With its highly innovative Pipeline, AiCuris addresses specialist markets and severe, potentially life-threatening infections with high medical need. Major steps for the company were signing a license agreement with Merck & Co. (MSD) and the marketing authorization for Prevymis™ (Letermovir) in the US and Europe.

 

Search Simple search